11-985531-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_012305.4(AP2A2):c.911C>T(p.Ala304Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,613,946 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.00012 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000014 ( 0 hom. )
Consequence
AP2A2
NM_012305.4 missense
NM_012305.4 missense
Scores
4
9
6
Clinical Significance
Conservation
PhyloP100: 7.73
Genes affected
AP2A2 (HGNC:562): (adaptor related protein complex 2 subunit alpha 2) The protein encoded by this gene is a subunit of the AP-2 adaptor protein complex, which is involved in linking lipid and protein membrane components with the clathrin lattice. This interaction supports the formation of clathrin-coated vesicles, and the encoded subunit aids in the process by binding polyphosphoinositide-containing lipids in the cell membrane. [provided by RefSeq, Nov 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAd4 at 19 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP2A2 | NM_012305.4 | c.911C>T | p.Ala304Val | missense_variant | 8/22 | ENST00000448903.7 | NP_036437.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AP2A2 | ENST00000448903.7 | c.911C>T | p.Ala304Val | missense_variant | 8/22 | 1 | NM_012305.4 | ENSP00000413234.3 | ||
AP2A2 | ENST00000332231.9 | c.914C>T | p.Ala305Val | missense_variant | 8/22 | 1 | ENSP00000327694.5 | |||
AP2A2 | ENST00000528815.5 | n.914C>T | non_coding_transcript_exon_variant | 8/21 | 2 | ENSP00000431630.1 | ||||
AP2A2 | ENST00000687792.1 | n.911C>T | non_coding_transcript_exon_variant | 8/21 | ENSP00000508951.1 | |||||
AP2A2 | ENST00000687890.1 | n.911C>T | non_coding_transcript_exon_variant | 8/21 | ENSP00000510756.1 | |||||
AP2A2 | ENST00000693238.1 | n.911C>T | non_coding_transcript_exon_variant | 8/20 | ENSP00000510648.1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152146Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
19
AN:
152146
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 249062Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135186
GnomAD3 exomes
AF:
AC:
6
AN:
249062
Hom.:
AF XY:
AC XY:
3
AN XY:
135186
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461682Hom.: 0 Cov.: 30 AF XY: 0.00000963 AC XY: 7AN XY: 727124
GnomAD4 exome
AF:
AC:
21
AN:
1461682
Hom.:
Cov.:
30
AF XY:
AC XY:
7
AN XY:
727124
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000125 AC: 19AN: 152264Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74446
GnomAD4 genome
AF:
AC:
19
AN:
152264
Hom.:
Cov.:
33
AF XY:
AC XY:
8
AN XY:
74446
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2024 | The c.914C>T (p.A305V) alteration is located in exon 8 (coding exon 8) of the AP2A2 gene. This alteration results from a C to T substitution at nucleotide position 914, causing the alanine (A) at amino acid position 305 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;D
M_CAP
Benign
T
MetaRNN
Uncertain
D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;L
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D
REVEL
Uncertain
Sift
Uncertain
D;T;D
Sift4G
Uncertain
D;D;D
Polyphen
D;.;D
Vest4
MVP
MPC
1.6
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at